We are live on ! Find out more
USNA icon

Usana Health Sciences
USNA

145 hedge funds and large institutions have $714M invested in Usana Health Sciences in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 66 increasing their positions, 36 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 36

20% more capital invested

Capital invested by funds: $593M → $714M (+$121M)

16% more call options, than puts

Call options by funds: $4.56M | Put options by funds: $3.92M

3.46% more ownership

Funds ownership: 42% → 45.46% (+3.5%)

6% less funds holding

Funds holding: 155 → 145 (-10)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

Holders
145
Holders Change
-10
Holders Change %
-6.45%
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
66
Reduced
36
Closed
25
Calls
$4.56M
Puts
$3.92M
Net Calls
+$636K
Net Calls Change
+$636K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$11.5M
2
Deutsche Bank
Deutsche Bank
Germany
+$6.89M
3
UBS Group
UBS Group
Switzerland
+$6.77M
4
Two Sigma Investments
Two Sigma Investments
New York
+$5.93M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.94M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$3.88M
2
Charles Schwab
Charles Schwab
California
-$2.03M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.53M
4
MWNA
Marshall Wace North America
New York
-$1.44M
5
AG
Algert Global
California
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
DZ Bank
26
DZ Bank
Germany
$5.36M +$3.08M +49,917 +148%
Millennium Management
27
Millennium Management
New York
$5.2M +$2.41M +39,103 +93%
Wellington Management Group
28
Wellington Management Group
Massachusetts
$5.04M +$1.18M +19,147 +32%
HA
29
Hays Advisory
Tennessee
$4.09M -$491K -7,971 -11%
Goldman Sachs
30
Goldman Sachs
New York
$4M +$376K +6,103 +11%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$3.92M +$167K +2,707 +5%
Prudential Financial
32
Prudential Financial
New Jersey
$3.53M -$907K -14,720 -21%
Ameriprise
33
Ameriprise
Minnesota
$3.03M +$164K +2,665 +6%
AQR Capital Management
34
AQR Capital Management
Connecticut
$2.86M +$156K +2,533 +6%
CEI
35
Clark Estates Inc
New York
$2.56M – – –
GCP
36
GSA Capital Partners
United Kingdom
$2.4M +$1.3M +21,140 +130%
MAM
37
Martingale Asset Management
Massachusetts
$2.36M +$62 +1 +0%
OAM
38
Oxford Asset Management
United Kingdom
$2.25M +$913K +14,812 +73%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$2.08M +$22.8K +370 +1%
BRF
40
B. Riley Financial
California
$1.92M +$1.85M +30,000 New
Barclays
41
Barclays
United Kingdom
$1.91M +$1.15M +18,615 +166%
RCAMU
42
Rothschild & Co Asset Management US
Connecticut
$1.87M +$18.4K +298 +1%
GS
43
GAM Systematic
United Kingdom
$1.76M +$1.23M +19,969 +264%
MC
44
Menta Capital
California
$1.76M -$961K -15,593 -36%
Wells Fargo
45
Wells Fargo
California
$1.75M -$259K -4,199 -13%
HI
46
HBK Investments
Texas
$1.71M +$24.6K +400 +2%
PPA
47
Parametric Portfolio Associates
Washington
$1.7M +$145K +2,347 +10%
PP
48
PDT Partners
New York
$1.57M +$444K +7,200 +42%
AIMCA
49
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.54M +$1.07M +17,300 +254%
GC
50
Globeflex Capital
California
$1.46M +$95K +1,541 +7%
1
2
3 4 5

USNA Hedge Fund Activity: Q2 2017 in Review

145 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2017, worth a combined $714M — up 20% from $593M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of USNA and 18 opened new positions — a net loss of 7 holders — while 36 trimmed existing stakes and 66 added.

The largest buyer was Renaissance Technologies, adding an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $3.88M.

  • 145 institutional investors held Usana Health Sciences (USNA) as of Q2 2017, down from 155 in Q1 2017.
  • Funds reported $714M of Usana Health Sciences stock for Q2 2017, up 20% quarter-over-quarter.
  • 18 funds opened new Usana Health Sciences positions in Q2 2017 and 25 closed out, a net change of -7 holders.
  • The largest Usana Health Sciences buyer in Q2 2017 was Renaissance Technologies, an estimated $11.5M added.
  • The largest Usana Health Sciences seller in Q2 2017 was Morgan Stanley, an estimated $3.88M sold.

Based on aggregated 13F filings for Q2 2017.